Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
Status:
Recruiting
Trial end date:
2023-07-20
Target enrollment:
Participant gender:
Summary
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase 2 Study
to Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of
Type 2 Diabetes Mellitus by Diet and Exercise